Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

03:06 EST 19th January 2019 | BioPortfolio

Showing News Articles 1–25 of 430,000+

Saturday 19th January 2019

FOLFIRINOX goes adjuvant

Patient Safety Movement Announces 273,077 Lives Saved

New Actionable Patient Safety Solution #17: Patient Safety Curriculum for Schools The Patient Safety Movement Foundation (PSMF) announced today at the 7th Annual Patient Safety, Science & Technology Summit that 90,146 lives were saved in 2018, thanks to the efforts of more than 4,710 hospitals committing to patient safety, and 89

The Elderly and Driving: When Is It Time to Hit the Brakes?

Prince Philip, 97, was involved in a car accident outside London. For families everywhere, the incident raises all-too-familiar questions.

Dr. John Mendelsohn, who led the prestigious University of Texas MD Anderson Cancer Center through an era of substantial growth, and who, as a scientist, helped pioneer a new type of cancer therapy, has died https://nyti.ms/2DkACjl 

Dr. John Mendelsohn, who led the prestigious University of Texas MD Anderson Cancer Center through an era of substantial growth, and who, as a scientist, helped pioneer a new type of cancer therapy, has died https://nyti.ms/2DkACjl 

EU5 Neurovascular Accessory Procedures Outlook to 2025 [Report Updated: 01122018] Prices from USD $3995

EU5 Neurovascular Accessory Procedures Outlook to 2025SummaryGlobalData's new report, EU5 Neurovascular Accessory Procedures Outlook to 2025, provides key procedures data on the EU5 Neurovascular Accessory Procedures. The report provides procedure volumes within market segments Microcatheters Procedures, Microguidewires Procedures and Support Catheters Procedures.The data in the report is derived...

Prognostic significance of MEOX2 in gliomas

Comparison of peak oxygen consumption response to aquatic and robotic therapy in individuals with chronic motor incomplete spinal cord injury: a randomized controlled trial

Wie Sanochemia, Snapchat, Dropbox ...

Das hat die BSNgine heute ausgewiesen.SAC: Sanochemia am 18.1. -9,40%, Volumen 10% normaler Tage , SEDG: SolarEdge am 18.1. -1,04%, Volumen 55% normaler Tage , FIT: Fitbit am 18.1. -0,98%, Volumen ...

Friday 18th January 2019

Nanning Xinzizhu to Distribute AOTI Wound Healing Device in China

Nanning Xinzizhu Trading acquired China distribution rights to a medical device aimed at treating chronic wounds made by AOTI of Oceanside, CA. AOTI developed the Topical Wound Oxygen (TWO2) device that delivers oxygen to chronic wounds, especially diabetic ulcers. Initially, both AOTI and Xinzizhu will work together to obtain NMPA registration of the TWO2 product line, while they increa...

STAT Plus: Atul Gawande has virtually disappeared from the public eye since he took the helm of a mysterious new health care company — and now he's withdrawing from a much-anticipated keynote address. https://buff.ly/2U0E0p0 

STAT Plus: Atul Gawande has virtually disappeared from the public eye since he took the helm of a mysterious new health care company — and now he's withdrawing from a much-anticipated keynote address. https://buff.ly/2U0E0p0 

Two recent reports mark important milestones in the area of biologics development -- http://ow.ly/xqKu30nn0mJ 

Two recent reports mark important milestones in the area of biologics development -- http://ow.ly/xqKu30nn0mJ 

Opinion: Diagnostic innovations are slowed by bureaucratic roadblocks. https://buff.ly/2DkzY5G 

Opinion: Diagnostic innovations are slowed by bureaucratic roadblocks. https://buff.ly/2DkzY5G 

. @bmsnews Buyout Not Stopping @Celgene from Launching Cancer Collaborations with @KynTherapeutics, @ObsidianTx: http://ow.ly/5T1Q30nn07p 

. @bmsnews Buyout Not Stopping @Celgene from Launching Cancer Collaborations with @KynTherapeutics, @ObsidianTx: http://ow.ly/5T1Q30nn07p 

[Corrections] Correction to Lancet Neurol 2019; 18: 145–54

LeWitt PA, Hauser RA, Pahwa R, et al, on behalf of the SPAN-PD Study Investigators. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Neurol 2019; 18: 145–54—In this Article, CVT-301 was incorrectly spelled in some instances in the Summary an...

STAT Plus: As Allergan tries to stall generic competition for its best-selling dry-eye drug Restasis, a small Canadian company is advancing its own medicine that could prove superior. https://buff.ly/2RArccd 

STAT Plus: As Allergan tries to stall generic competition for its best-selling dry-eye drug Restasis, a small Canadian company is advancing its own medicine that could prove superior. https://buff.ly/2RArccd 

Venom Goes to Bat as Novel Medical Treatment: http://ow.ly/8Jed30nn09i 

Venom Goes to Bat as Novel Medical Treatment: http://ow.ly/8Jed30nn09i 

Apple-Zulieferer Foxconn entlässt zehntausende Leiharbeiter

Der wichtigste Apple-Zulieferer Foxconn hat überraschend früh zehntausende Leiharbeiter entlassen. Der Apple-Zulieferer Foxconn hat sich einem Medienbericht zufolge seit Oktober von rund 50.000 Lei...

Opinion: Places all around the world are using drones to deliver medical supplies that save lives. The U.S. should be doing the same. https://buff.ly/2W2x64D 

Opinion: Places all around the world are using drones to deliver medical supplies that save lives. The U.S. should be doing the same. https://buff.ly/2W2x64D 

UNIST researcher recognized with 2018 Merck Life Science Awards

(Ulsan National Institute of Science and Technology(UNIST)) Jun Ho Lee, a doctroral student in Life Sciences at South Korea's Ulsan National Institute of Science and Technology (UNIST), named a recipient of 2018 Life Science Awards.

Seven UNIST researchers named 'world's most highly cited researchers'

(Ulsan National Institute of Science and Technology(UNIST)) Seven faculty members of South Korea's Ulsan National Institute of Science and Technology (UNIST) have distinguished themselves with inclusion in the Global Highly Cited Researchers 2018 List.

UNIST student wins prestigious 2018 Red Dot Award: Design concept

(Ulsan National Institute of Science and Technology(UNIST)) A student, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has been named a winner of the 2018 prestigious "Red Dot Award" for design concept.

New study reveals local drivers of amplified Arctic warming

(Ulsan National Institute of Science and Technology(UNIST)) An international team of researchers, including Professor Sarah Kang and DoYeon Kim in the School of Urban and Environmental Engineering at South Korea's Ulsan National Institute of Science and Technology (UNIST), has unveiled local drivers of amplified arctic warming.

#Obesity-Regulating Brain Signaling Pathway Genes Identified: http://ow.ly/RsI030nmFIg 

#Obesity-Regulating Brain Signaling Pathway Genes Identified: http://ow.ly/RsI030nmFIg 

Russia Neurology Procedures Outlook to 2025 Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others [Report Updated: 01122018] Prices from USD $3995

Russia Neurology Procedures Outlook to 2025 Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and OthersSummaryGlobalData's new report, Russia Neurology Procedures Outlook to 2025, provides key procedures data on the Russia Neurology Procedures. The report provides procedure volumes within market categories Dura Substitute Procedures, Hydrocephalus Shunting...

Qualcomm erwirkt einstweilige Verfügung gegen Apple in Deutschland: Der Patentstreit zwischen Apple ...

Der Patentstreit zwischen Apple und Qualcomm in Deutschland geht weiter: Nun soll der Chipkonzern eine einstweilige Verfügung gegen den iPhone-Hersteller bewirkt haben.Das Landgericht München unter...


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device tracking service collates press releases, news articles and blogs from over 500 sources.  Continuous news is published on the BioPortfolio site, categorised into core topics and posted to our social media accounts - currently 127,000 followers (January 2019):